搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Cytophaga hutchinsonii Phosphopantetheine adenylyltransferase (coaD) CSB-YP606255CAAO
CSB-EP606255CAAO
CSB-BP606255CAAO
CSB-MP606255CAAO
CSB-EP606255CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii 50S ribosomal protein L9 (rplI) CSB-YP606256CAAO
CSB-EP606256CAAO
CSB-BP606256CAAO
CSB-MP606256CAAO
CSB-EP606256CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP606257CAAO
CSB-EP606257CAAO
CSB-BP606257CAAO
CSB-MP606257CAAO
CSB-EP606257CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii SsrA-binding protein (smpB) CSB-YP606258CAAO
CSB-EP606258CAAO
CSB-BP606258CAAO
CSB-MP606258CAAO
CSB-EP606258CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii 30S ribosomal protein S20 (rpsT) CSB-YP606259CAAO
CSB-EP606259CAAO
CSB-BP606259CAAO
CSB-MP606259CAAO
CSB-EP606259CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Pyridoxine/pyridoxamine 5'-phosphate oxidase (pdxH) CSB-YP606260CAAO
CSB-EP606260CAAO
CSB-BP606260CAAO
CSB-MP606260CAAO
CSB-EP606260CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Bifunctional protein FolD (folD) CSB-YP606261CAAO
CSB-EP606261CAAO
CSB-BP606261CAAO
CSB-MP606261CAAO
CSB-EP606261CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii 50S ribosomal protein L35 (rpmI) CSB-YP606262CAAO
CSB-EP606262CAAO
CSB-BP606262CAAO
CSB-MP606262CAAO
CSB-EP606262CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP606263CAAO
CSB-EP606263CAAO
CSB-BP606263CAAO
CSB-MP606263CAAO
CSB-EP606263CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Alanine--tRNA ligase (alaS), partial CSB-YP606264CAAO
CSB-EP606264CAAO
CSB-BP606264CAAO
CSB-MP606264CAAO
CSB-EP606264CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii NADH-quinone oxidoreductase subunit B 2 (nuoB2) CSB-YP606265CAAO
CSB-EP606265CAAO
CSB-BP606265CAAO
CSB-MP606265CAAO
CSB-EP606265CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii NADH-quinone oxidoreductase subunit N (nuoN), partial CSB-YP606266CAAO
CSB-EP606266CAAO
CSB-BP606266CAAO
CSB-MP606266CAAO
CSB-EP606266CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Leucine--tRNA ligase (leuS), partial CSB-YP606267CAAO
CSB-EP606267CAAO
CSB-BP606267CAAO
CSB-MP606267CAAO
CSB-EP606267CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Urease accessory protein UreG (ureG) CSB-YP606268CAAO
CSB-EP606268CAAO
CSB-BP606268CAAO
CSB-MP606268CAAO
CSB-EP606268CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii UDP-3-O-acylglucosamine N-acyltransferase (lpxD) CSB-YP606269CAAO
CSB-EP606269CAAO
CSB-BP606269CAAO
CSB-MP606269CAAO
CSB-EP606269CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii 5'-nucleotidase surE (surE) CSB-YP606270
CSB-EP606270
CSB-BP606270
CSB-MP606270
CSB-EP606270-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP606271CAAO
CSB-EP606271CAAO
CSB-BP606271CAAO
CSB-MP606271CAAO
CSB-EP606271CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Guanylate kinase (gmk) CSB-YP606272CAAO
CSB-EP606272CAAO
CSB-BP606272CAAO
CSB-MP606272CAAO
CSB-EP606272CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii NADH-quinone oxidoreductase subunit D 1 (nuoD1) CSB-YP606273CAAO
CSB-EP606273CAAO
CSB-BP606273CAAO
CSB-MP606273CAAO
CSB-EP606273CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii 50S ribosomal protein L27 (rpmA) CSB-YP606274CAAO
CSB-EP606274CAAO
CSB-BP606274CAAO
CSB-MP606274CAAO
CSB-EP606274CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>